The McFadden lab uses genetically engineered mice and human cancer cells to identify new genes and small molecules that regulate cancer cell growth.

The broad research interest of Fei Wang lab is in dissecting molecular mechanisms of essential membrane-associated cellular events in eukaryotic cell development.

Goldsmith Lab combines drug discovery and mechanistic analysis to understanding protein kinases. 

The De Brabander Lab focuses on the synthesis of complex molecular architectures, including both designed and naturally occurring substances with novel structural features and interesting biological function. 

The Mangelsdorf/Kliewer Lab studies two signal transduction pathways that offer new therapeutic potential for treating diseases such as diabetes, obesity, cancer, and parasitism.

Qin Lab focuses on the development of novel synthetic transformations and strategies that will allow access to bioactive, complex natural products and efficient synthesis of pharmaceuticals and their derivatives.

The Ready Lab is engaged in the discovery and synthesis of biologically active small molecules

The Orth lab is interested in elucidation the activity of virulence factors from pathogenic bacteria so that we can gain novel molecular insight into eukaryotic signaling systems.

The Tambar Group develops new strategies and concepts in synthetic chemistry to address challenging problems in chemistry and biology.

Our lab works with murine disease models and employs Biochemistry, Molecular and Cell Biology to investigate brain glycogen metabolism and related neurodegenerative diseases.